Almi Invest

PainDrainer AB is a Swedish company established in 2018, focused on developing innovative solutions for individuals suffering from chronic pain and conditions. The company offers a cloud-based application that serves as a self-management coaching tool for patients. This application helps users identify their pain triggers and protectors, track daily activities, and analyze their pain patterns. By utilizing advanced artificial intelligence, PainDrainer's tool provides personalized coaching and guidance on how to plan daily activities to minimize pain and enhance overall quality of life. The company aims to address unmet clinical needs in the management of chronic, non-malignant pain, serving both patients and healthcare partners, including those involved in clinical trials.

Readily Diagnostics develops rapid and accurate diagnostic tests for respiratory disorders, enabling healthcare professionals to identify and treat infections more efficiently at the point of care.

Trackpaw Scientific focuses on the development and commercialization of a technology platform aimed at enhancing the efficiency of medication development. The company has created an animal research monitoring platform that improves research quality while minimizing the use of animals. This platform monitors weight, activity, and behavior, offering various modes applicable to a wide range of behavioral studies. It features an alarm system that alerts researchers only when abnormal behaviors are detected, allowing for better data quality and reduced animal usage. By automating tasks, Trackpaw Scientific contributes to improved research quality, reduces animal stress, and addresses the ethical considerations surrounding animal research.

Utilizer develops point-of-care diagnostic tests for bacterial infections. Their test kits can detect and quantify bacteria in clinically relevant ranges without complex lab instruments, enabling non-trained operators to identify urinary tract infections at home using a simple cell phone camera.

Amferia AB is a medical device company based in Mölndal, Sweden, focused on addressing the global antibiotic resistance crisis. Founded in 2018, Amferia specializes in the development of innovative anti-infective medical devices aimed at preventing bacterial infections, particularly those caused by antibiotic-resistant bacteria. The company's primary emphasis is on the wound care sector, where it produces preventive care wound patches designed to combat the increasing threat of antibiotic-resistant skin infections. Amferia's proprietary anti-infective technology, developed through years of research at Chalmers University of Technology, is patent protected, underscoring the company's commitment to enhancing infection control and improving patient outcomes in healthcare settings.

Countagen develops consumable reagent kits that enable precise analysis of gene editing efficiency and specificity using standard lab equipment. This affordable solution accelerates genetic research and saves costs for healthcare providers.

PainDrainer AB is a Swedish company established in 2018, focused on developing innovative solutions for individuals suffering from chronic pain and conditions. The company offers a cloud-based application that serves as a self-management coaching tool for patients. This application helps users identify their pain triggers and protectors, track daily activities, and analyze their pain patterns. By utilizing advanced artificial intelligence, PainDrainer's tool provides personalized coaching and guidance on how to plan daily activities to minimize pain and enhance overall quality of life. The company aims to address unmet clinical needs in the management of chronic, non-malignant pain, serving both patients and healthcare partners, including those involved in clinical trials.

Molecular Attraction is a research and development firm focused on creating innovative solutions for vector-borne disease control and eradication. The company specializes in identifying biological compounds that can influence the behavior of various vector organisms, including mosquitoes, ticks, flies, and rodents. By utilizing sustainable technology and chemical blends, Molecular Attraction aims to provide effective, long-lasting, and low-maintenance pest control solutions. Their approach is designed to enhance the efficacy of vector-borne disease management while prioritizing environmental sustainability and cost-effectiveness within the pest control industry.

Eatit operates a digital therapeutics platform designed to facilitate weight loss through personalized diet plans. The platform connects users with qualified dietitians via video calls or chat, creating tailored programs based on individual relationships with food and lifestyle habits.

Migränhjälpen is a digital health service provider that specializes in offering support for patients suffering from severe headaches and migraines. The company operates a digital specialist clinic where patients can access a range of services, including a digital diary to monitor migraine attacks and virtual consultations with healthcare professionals for accurate diagnosis and treatment. Additionally, Migränhjälpen features a digital nurse facility, enabling patients to receive immediate care conveniently, regardless of their geographical location. This innovative approach aims to simplify the management of migraine-related issues and enhance patient accessibility to necessary medical support.

Ally provides health, e-health, digital health, house calls, and telemedicine to help people stay healthy. They bring doctors and nurses to patients for on-demand house calls. They combine the digital with the human encounter between patient and healthcare provider. They provide home visits, home visits by nurses with doctors through video links, and checkup services.

PreVet is a Swedish digital platform that connects pet and horse owners with veterinarians. The service provides a tool to gather and update animal information, share profiles and disease history with veterinarians, and manage routines for home care with reminders and educational content such as instructional videos. By enabling owners and veterinarians to view health activities and development, it supports counseling, diagnosis, and treatment decisions. The company was founded in 2017 and is based in Uppsala, Sweden.

Preactly is a company that specializes in developing HR software-as-a-service (SAAS) tools aimed at enhancing digital work environments for businesses. Their tools are designed to support both employers and employees by facilitating the assessment, survey, and analysis of workplace conditions. Preactly's offerings include actionable plans with specific goals and follow-up measures that help organizations improve their work environments and foster greater employee engagement. By focusing on sustainable working practices, Preactly aims to create attractive workplaces that benefit both the organization and its workforce.

Profundus AB, based in Gothenburg, Sweden, specializes in the research and development of advanced imaging technology for retinal diagnostics. The company is developing a proof-of-concept prototype for a novel fundus camera that utilizes adaptive optics, a technology originally designed for terrestrial telescopes. This innovative approach significantly enhances imaging resolution, offering 7-10 times greater clarity than conventional devices while covering a larger area of the retina. The primary goal of Profundus AB is to create a clinical tool that aids in the diagnosis of retinal diseases by visualizing subclinical changes that may otherwise go unnoticed.

Developeration AB is a Swedish company established in 2016, located in Enskede. It specializes in the research and development of medical devices aimed at the surgical treatment of hemorrhoids. The company is focused on creating an innovative device designed to facilitate surgery without the need for anesthesia, which is expected to reduce postoperative pain and significantly lower treatment costs by 70%.

Migränhjälpen is a digital health service provider that specializes in offering support for patients suffering from severe headaches and migraines. The company operates a digital specialist clinic where patients can access a range of services, including a digital diary to monitor migraine attacks and virtual consultations with healthcare professionals for accurate diagnosis and treatment. Additionally, Migränhjälpen features a digital nurse facility, enabling patients to receive immediate care conveniently, regardless of their geographical location. This innovative approach aims to simplify the management of migraine-related issues and enhance patient accessibility to necessary medical support.

MediTuner AB, founded in 2014 and based in Stockholm, Sweden, develops a digital solution aimed at empowering patients with asthma through its clinically validated app, AsthmaTuner. This application connects to a spirometer, allowing users to measure their asthma levels and receive personalized treatment recommendations based on international guidelines. By automating the process and providing tailored advice, AsthmaTuner not only supports patients in managing their condition more effectively but also aids caregivers in their efforts to ensure better asthma control. Through this innovative approach, MediTuner enhances the patient's ability to take control of their asthma while streamlining healthcare delivery.

Celluminova AB is a Swedish company based in Norrköping that specializes in developing innovative tools for stem cell research, particularly focusing on cancer stem cells. The company's flagship product, GlioStem, is designed to detect neural stem cells and progenitors derived from glioma. By utilizing a unique fluorescent molecule, GlioStem binds specifically to cancer stem cells, enabling researchers and healthcare professionals to visualize and determine the presence of these cells in tissue samples after medical interventions. This capability enhances the precision of cancer diagnostics and treatment monitoring. Celluminova also offers its products for sale through its website, making its advanced research tools accessible to the scientific community.

Amferia AB is a medical device company based in Mölndal, Sweden, focused on addressing the global antibiotic resistance crisis. Founded in 2018, Amferia specializes in the development of innovative anti-infective medical devices aimed at preventing bacterial infections, particularly those caused by antibiotic-resistant bacteria. The company's primary emphasis is on the wound care sector, where it produces preventive care wound patches designed to combat the increasing threat of antibiotic-resistant skin infections. Amferia's proprietary anti-infective technology, developed through years of research at Chalmers University of Technology, is patent protected, underscoring the company's commitment to enhancing infection control and improving patient outcomes in healthcare settings.

Aligned Bio specializes in developing advanced biosensor platforms using patented nanowire production methods. Their sensors are designed for applications such as biomedicine, water purification, public safety, and electronics, offering high sensitivity, accuracy, and speed.

Alertix Veterinary Diagnostics is a Swedish biotechnology company founded in 2017 and headquartered in Kalmar. It develops immunodiagnostic assays that measure thymidine kinase 1 (TK1), a biomarker of tumor growth and cell turnover, in blood from dogs, cats, and horses. The assays are designed for early cancer detection and monitoring and include tests for canine, feline, and equine TK1, supported by cancer testing services. The company focuses on translating Swedish veterinary biotech research into practical diagnostics for veterinary patients.

Founded in 2013, Linkura develops wearable devices for companies to monitor employee health metrics including stress levels, sleep patterns, physical activities, and sedentary behavior.

BioReperia specializes in accelerating drug discovery using zebrafish tumor xenograft technology. With over a decade of experience, they offer services to predict effective cancer treatments and identify drug actions and toxicity, enhancing precision and speed in pre-clinical development.

Learning to Sleep specializes in evidence-based digital programs for improving sleep quality. It offers two main products: 'Improve My Sleep' for mild cases and 'Learning to Sleep' for more severe issues, both distributed via web and mobile platforms. Founded in 2010, the company is headquartered in Malmo, Sweden.

Empe Diagnostics specializes in developing rapid diagnostic solutions for infectious diseases, particularly targeting drug-resistant Tuberculosis (TB) and Sexually Transmitted Diseases (STDs). The company focuses on creating simple and efficient diagnostic kits that facilitate combinatorial and confirmatory point-of-care testing. By prioritizing early-stage diagnostics, Empe Diagnostics aims to enhance patient access to timely and accurate testing for these infections, ultimately contributing to the fight against antimicrobial resistance.

HiloProbe AB is a biotechnology company founded in 2016 and based in Umeå, Sweden. The company specializes in the development of innovative diagnostic techniques for cancer treatment, focusing on its flagship product, ColoNode. This biomarker test provides a highly accurate and rapid method for detecting and characterizing cancer cells in lymph nodes, particularly in cases of colorectal cancer. By enabling precise analysis of cancer cell spread, HiloProbe's technology assists healthcare professionals in assessing the aggressiveness of cancer and determining the most appropriate treatment options for patients following surgery.

Neosense Technology is an innovative start-up focused on enhancing patient care in intensive care units through advanced continuous oxygen monitoring systems. The company specializes in developing real-time monitoring solutions that accurately measure blood oxygen levels, particularly for premature infants. By maintaining precise oxygenation levels, Neosense's technology aims to minimize the risk of complications and prevent potential eye damage in vulnerable patients. The company's commitment to improving safety and control in oxygen management positions it as a key player in critical care healthcare solutions.

Presscise develops innovative compression products for global markets in medical, sports, and veterinary medicine. Their flagship product is a precision-controlled bandage system designed to safely treat chronic bone diseases like scleroderma, leg ulcers, and edema.

Racefox, headquartered in Stockholm, Sweden, specializes in digital coaching for running and cross-country skiing. Utilizing a combination of biomechanics research, sports science, data science, and AI, the company's application provides personalized training plans and real-time performance metrics. By analyzing users' movements and identifying potential issues, Racefox helps enhance performance and prevent injuries, catering to both elite athletes and recreational enthusiasts seeking to improve their skills and maintain a healthy lifestyle.

Founded in Sweden in 2011, Brain Stimulation specializes in innovative neurological rehabilitation. They leverage brain plasticity research to develop effective, individualized care for stroke, dementia, traumatic brain injuries, and other degenerative brain diseases.

Monivent AB is a medtech company based in Gothenburg, Sweden, founded in 2013. It specializes in developing, manufacturing, and selling medical technology products aimed at improving respiratory support for newborns at birth. The company’s flagship product, the Monivent Neo100, features a specially designed face mask equipped with an integrated sensor module that measures airflow during manual ventilation. This device provides continuous feedback on the volume of air delivered, allowing healthcare staff to administer the appropriate amount of ventilation based on the infant's weight, thereby minimizing the risk of lung damage. Monivent also offers training services to ensure effective use of its technology.

Nordic Health Innovation AB (NHI) is an entrepreneurial company based in Storuman, Västerbotten, focused on enhancing healthcare accessibility through innovative technology. In collaboration with the Glesbygdsmedicinsk Centrum (GMC), NHI develops a virtual health room software that facilitates flexible and standardized virtual healthcare services for both public and private customers. This platform empowers individuals to conduct self-administered health checks while maintaining access to professional healthcare, thereby enabling physicians to provide enhanced care. By prioritizing cost-effectiveness and accessibility, Nordic Health Innovation strives to create equal healthcare opportunities for all.

Glycobond is a biotechnology company focused on the development and production of proprietary carbohydrate-binding reagents for diagnostics. The company specializes in creating peptides that detect aberrant and cancer-specific glycosylation, primarily targeting alpha-1 acid glycoprotein (AGP), which is produced mainly in the liver. Glycobond's flagship product, HepaCheC™, is an ELISA-based assay that enables the detection of these specific glycosylation patterns through simple blood sample analysis. Utilizing a patented fucose-binding protein known as Mono-F, this assay has demonstrated promising results in monitoring patients at risk of developing hepatocellular carcinoma (HCC) through longitudinal serum sample analyses. Glycobond's innovations aim to enhance the diagnosis and monitoring of liver diseases and cancer, providing valuable tools for healthcare professionals.

Life Genomics AB, founded in 2014 in Gothenburg, Sweden, specializes in genetic testing services for both the healthcare industry and the general public. Originating as a spin-off from TATAA Biocenter, the company operates a laboratory that is recognized as one of Europe's premier facilities in this field. Life Genomics provides a range of tests, including fetal tests, carrier tests, and diagnostic services for conditions such as Alzheimer's disease. By offering state-of-the-art genetic testing, the company aims to enhance access to vital healthcare information for individuals and wellness providers.

MedFilm is a company focused on enhancing patient understanding of surgical interventions through the use of animated films. It specializes in creating three-dimensional animated patient films available in over a dozen languages, aimed at simplifying the communication of operations and treatments. These films are utilized in hospitals throughout Scandinavia, providing essential information to patients both upon admission and during recovery. Additionally, MedFilm's content is displayed on waiting room screens and made accessible online, ensuring that patients can easily access information about their procedures. By improving comprehension and encouraging patient participation, MedFilm supports healthcare providers in delivering better care.

Chundsell Medicals AB, founded in 2007 as a spin-off from Karolinska Institutet in Solna, Sweden, specializes in developing diagnostic tests for prostate cancer. The company aims to improve early treatment decisions through its flagship product, the Prostatype® Test System. This system evaluates the aggressiveness of prostate cancer by analyzing the expression patterns of three specific embryonic stem cell genes in tumor tissue specimens. By integrating these genetic insights with established clinical parameters, Chundsell Medicals provides healthcare professionals with valuable information to predict patient outcomes, including overall and cancer-specific survival rates. The company focuses on translating cutting-edge research in prostate cancer genomics into practical solutions for clinical use.

MedUniverse is a developer of a digital patient case engagement platform aimed at enhancing the quality of interactions between patients and healthcare providers. The company's software is designed to bridge the information gap between patients and stakeholders in the life science industry. By facilitating better communication and engagement, MedUniverse's platform aims to improve decision-making processes, ultimately leading to better patient outcomes. The company focuses on delivering an easy-to-use solution that empowers healthcare organizations to interact with patients more effectively, ensuring that critical patient information is communicated clearly and efficiently.

LeguPro’s mission is to make it easier and more affordable for the average consumer to eat a healthy, sustainable diet. In a wave of increased health awareness, the global population is paying more and more attention to the food it eats. People are becoming more concerned about the overall quality of their food, including how their food affects their health, whether the food is highly processed, the additives and preservatives contained in their food, the taste of their food, and the fat content and number of calories in the food. These health-driven trends are influencing overall lifestyles of consumers and affecting their product choices. These busy consumers want eating to be healthy, sustainable, and affordable, and LeguPro will provide practical kitchen appliances and cooking aids to meet their needs.

Schemagi AB specializes in providing scheduling and business consulting services, particularly for the care sector. The company employs advanced analyses and proprietary optimization tools to support decision-making in strategic staffing and planning issues. Originating from optimization studies at Linköping University, Schemagi has developed unique scheduling solutions tailored to meet the specific needs of its clients. In 2016, Schemagi partnered with a management consultancy specializing in healthcare, expanding its offerings to include comprehensive production and capacity planning services. This collaboration allows the company to approach projects with a holistic perspective, from initial political orders to finalized schedules. Schemagi employs a team of permanent consultants and collaborates with a broad network of professionals to ensure the right expertise is available for each assignment, thereby enhancing efficiency in crew and schedule management for its clients.

SARomics Biostructures AB is a Swedish company specializing in structural biology and structure-based drug discovery services for biotech and pharmaceutical companies, as well as non-profit institutions globally. Founded in 2006 and located in Lund, the company provides a comprehensive suite of services that includes crystallography, NMR spectroscopy, and gene-to-structure solutions, which encompass protein cloning, expression, purification, and structure determination. Additionally, SARomics offers kinase structures and related programs, hit identification, optimization services, and computational chemistry. Their work aids clients in understanding the interactions between drug substances and target molecules, facilitating the efficient development of new drugs. The company’s expertise in protein characterization and structure-activity relationship optimization further enhances its capability to support drug discovery projects from initial concept through to lead generation.

Hemcheck Sweden AB is a medical technology company based in Karlstad, Sweden, established in 2010. The company specializes in developing and commercializing a product named Helge, which is designed to detect hemolysis in blood samples at the point of care. Hemolysis, the breakdown of red blood cells, often results in blood samples being unfit for analysis, leading to suboptimal patient care and increased costs for healthcare systems. By providing immediate detection of hemolysed blood samples during the sampling process, Hemcheck aims to enhance patient outcomes and streamline healthcare delivery in emergency departments across the European Union and the United States.

Founded in 2007, Likvor specializes in neurological investigation systems. Its flagship product, the CELDA System, assesses cerebrospinal fluid dynamics, enabling accurate diagnosis and monitoring of conditions like Normal Pressure Hydrocephalus (NPH) and shunt functionality.

Schemagi AB specializes in providing scheduling and business consulting services, particularly for the care sector. The company employs advanced analyses and proprietary optimization tools to support decision-making in strategic staffing and planning issues. Originating from optimization studies at Linköping University, Schemagi has developed unique scheduling solutions tailored to meet the specific needs of its clients. In 2016, Schemagi partnered with a management consultancy specializing in healthcare, expanding its offerings to include comprehensive production and capacity planning services. This collaboration allows the company to approach projects with a holistic perspective, from initial political orders to finalized schedules. Schemagi employs a team of permanent consultants and collaborates with a broad network of professionals to ensure the right expertise is available for each assignment, thereby enhancing efficiency in crew and schedule management for its clients.

Aligned Bio specializes in developing advanced biosensor platforms using patented nanowire production methods. Their sensors are designed for applications such as biomedicine, water purification, public safety, and electronics, offering high sensitivity, accuracy, and speed.